Effects of xenoestrogens on streptozotocin-induced diabetic mice

Journal of Physiology and Pharmacology

Volumn 65, Issue 2, 2014, Pages 273-282

  Kang, H S ^a   Yang, H ^a   Ahn, C ^a   Kang, H Y ^a   Hong, E J ^a   Jeung, Eui Bae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Apoptosis; Bisphenol A; Diabetes; Estrogen; Gluconeogenesis; Insulin; Liver; Pancreatic; Streptozotocin; cell

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; BETA ACTIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; OCTYLPHENOL; PHENOL DERIVATIVE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN BCL 2; PROTEIN BCL XL; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XENOESTROGEN; 4,4' ISOPROPYLIDENEDIPHENOL; BCL2L1 PROTEIN, MOUSE; BENZHYDRYL DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; MAFA PROTEIN, MOUSE; NF-KAPPAB INHIBITOR ALPHA; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; PROTEIN BCL X; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR MAF; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANALYSIS; ANIMAL; BLOOD; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ANIMALS; BCL-X PROTEIN; BENZHYDRYL COMPOUNDS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTE NUCLEAR FACTOR 4; HOMEODOMAIN PROTEINS; I-KAPPA B PROTEINS; INSULIN; INSULIN-SECRETING CELLS; INTERLEUKIN-1; LIVER; MAF TRANSCRIPTION FACTORS, LARGE; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; PHENOLS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA; XENOBIOTICS;

EID: 84899632929     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Neubauer N, Kulkarni RN. Molecular approaches to study control of glucose homeostasis. ILAR J 2006; 47: 199-211.
2. Robertson RP. Prostaglandins, glucose homeostasis, and diabetes mellitus. Annu Rev Med 1983; 34: 1-12.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 1): S62-S69.
4. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005; 2: 5.
5. Wolever TM, Mehling C. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 2003; 77: 612-621.
6. Lansang MC, Hustak LK. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them. Cleve Clin J Med 2011; 78: 748-756.
7. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 537-546.
8. Feher D, Gyorffi A, Fazekas A. Neurogenic inflammation of gingivomucosal tissue in streptozotocin-diabetic rat. Arch Physiol Biochem 2001; 109: 230-233.
9. Graham ML, Janecek JL, Kittredge JA, Hering BJ, Schuurman HJ. The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources. Comp Med 2011; 61: 356-360.
10. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000; 43: 1528-1533.
11. Lenzen S. The mechanisms of alloxan-and streptozotocininduced diabetes. Diabetologia 2008; 51: 216-226.
12. Soltysik K, Czekaj P. Membrane estrogen receptors-is it an alternative way of estrogen action? J Physiol Pharmacol 2013; 64: 129-142.
13. Wojcik M, Bobowiec R, Lisiecka U, Kostro K. Proliferation, differentiation and apoptosis of choline deficient ethionine supplemented diet-rat oval cells under the influence of 2-methoxyestradiol. J Physiol Pharmacol 2012; 63: 669-676.
14. Yamabe N, Kang KS, Zhu BT. Beneficial effect of 17betaestradiol on hyperglycemia and islet beta-cell functions in a streptozotocin-induced diabetic rat model. Toxicol Appl Pharmacol 2010; 249: 76-85.
15. Le May C, Chu K, Hu M, et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 2006; 103: 9232-9237.
16. Liu S, Le May C, Wong WP, et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009; 58: 2292-2302.
17. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 2013; 34: 309-338.
18. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114: 106-112.
19. Nicolopoulou-Stamati P, Pitsos MA. The impact of endocrine disrupters on the female reproductive system. Hum Reprod Update 2001; 7: 323-330.
20. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 1998; 65: 143-150.
21. An BS, Ahn HJ, Kang HS, et al. Effects of estrogen and estrogenic compounds, 4-tert-octylphenol, and bisphenol A on the uterine contraction and contraction-associated proteins in rats. Mol Cell Endocrinol 2013; 375: 27-34.
22. Ahn HJ, An BS, Jung EM, Yang H, Choi KC, Jeung EB. Parabens inhibit the early phase of folliculogenesis and steroidogenesis in the ovaries of neonatal rats. Mol Reprod Dev 2012; 79: 626-636.
23. Kim S, An BS, Yang H, Jeung EB. Effects of octylphenol and bisphenol A on the expression of calcium transport genes in the mouse duodenum and kidney during pregnancy. Toxicology 2013; 303: 99-106.
24. Kim SM, Jung EM, An BS, et al. Additional effects of bisphenol A and paraben on the induction of calbindin-D(9K) and progesterone receptor via an estrogen receptor pathway in rat pituitary GH3 cells. J Physiol Pharmacol 2012; 63: 445-455.
25. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008; 3: e2069.
26. Batista TM, Alonso-Magdalena P, Vieira E, et al. Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS One 2012; 7: e33814.
27. Kim YR, Jung EM, Choi KC, Jeung EB. Synergistic effects of octylphenol and isobutyl paraben on the expression of calbindin-D(9)k in GH3 rat pituitary cells. Int J Mol Med 2012; 29: 294-302.
28. Nakagomi M, Suzuki E, Usumi K, et al. Effects of endocrine disrupting chemicals on the microtubule network in Chinese hamster V79 cells in culture and in Sertoli cells in rats. Teratog Carcinog Mutagen 2001; 21: 453-462.
29. Braniste V, Jouault A, Gaultier E, et al. Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc Natl Acad Sci USA 2010; 107: 448-453.
30. Wu KK, Huan Y. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2008; Chapter 5: Unit 5 47.
31. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic betacells. Biochem J 2008; 415: 1-10.
32. Wei M, Ong L, Smith MT, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ 2003; 12: 44-50.
33. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994; 43: 1326-1333.
34. Saini KS, Thompson C, Winterford CM, Walker NI, Cameron DP. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem Mol Biol Int 1996; 39: 1229-1236.
35. Wender-Ozegowska E, Zawiejska A, Michalowska-Wender G, Iciek R, Wender M, Brazert J. Metabolic syndrome in type 1 diabetes mellitus. Does it have any impact on the course of pregnancy? J Physiol Pharmacol 2011; 62: 567-573.
36. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 2003; 285: E685-E692.
37. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999; 19: 379-406.
38. Edgerton DS, Ramnanan CJ, Grueter CA, et al. Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes 2009; 58: 2766-2775.
39. Kahn CR, Lauris V, Koch S, Crettaz M, Granner DK. Acute and chronic regulation of phosphoenolpyruvate carboxykinase mRNA by insulin and glucose. Mol Endocrinol 1989; 3: 840-845.
40. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 1992; 54: 885-909.
41. Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys 2007; 48: 89-95.
42. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997; 66: 581-611.
43. Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006; 55: 819-825.
44. Xie X, Liao H, Dang H, et al. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol Endocrinol 2009; 23: 434-443.
45. Faideau B, Larger E, Lepault F, Carel JC, Boitard C. Role of beta-cells in type 1 diabetes pathogenesis. Diabetes 2005; 54 (Suppl 2): S87-S96.
46. Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes 2008; 57: 2863-2871.
47. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1029-L1037.
48. Salakou S, Kardamakis D, Tsamandas AC, et al. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 2007; 21: 123-132.
49. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-1132.
50. Kim S, Millet I, Kim HS, et al. NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 2007; 104: 1913-1918.
51. Jafari Anarkooli I, Sankian M, Ahmadpour S, Varasteh AR, Haghir H. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Exp Diabetes Res 2008; 2008: 638467.
52. Lian HD, Ren B, Gao XW. Effects of minocycline on expression of bcl-2, bax in early retinal neuropathy of diabetes in rats. Int J Ophthalmol 2011; 4: 162-164.